Month: July 2025

Park National Corporation names Matthew R. Miller Chief Executive Officer; David L. Trautman to continue as Board Chair

Written by Customer Service on July 29, 2025. Posted in Public Companies.

David L. TrautmanDavid L. TrautmanMatthew R. MillerMatthew R. MillerNEWARK, Ohio, July 29, 2025 (GLOBE NEWSWIRE) — Park National Corporation (Park) (NYSE American: PRK) has named Matthew R. Miller Chief Executive Officer of Park National Corporation and Park National Bank effective January 1, 2026. Miller will retain his title as president. David L. Trautman will continue to serve as Chair of the Board. “I have worked closely with Matt for the past 10 years,” said Trautman. “I have witnessed his commitment to our community, his passion for service and his dedication to making this place the best it can be. He has proven to the board, to our colleagues and to me that it is time for the final authority to rest with him.” As part of its succession planning, Park’s board of directors conducted a thorough evaluation...

Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025

Written by Customer Service on July 29, 2025. Posted in Public Companies.

DUBLIN, Ireland and CHICAGO, July 29, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the Company will release its second quarter 2025 financial results before the open of the U.S. financial markets on Tuesday, August 5, 2025. Management will host a conference call at 8:30 a.m. ET that day to discuss the Company’s financial results and provide an update on its business. To access the call please dial 833-470-1428 (domestic) or 404-975-4839 (international) and refer to Access Code 740801. To pre-register for this call, please go to the following link: https://events.q4inc.com/attendee/143945533. The audio webcast...

Introducing Element Mobility – a Strategic Division to Drive the Future of Intelligent Fleet Technology

Written by Customer Service on July 29, 2025. Posted in Public Companies.

Element Fleet Management is advancing its leadership in fleet and mobility innovation with the launch of Element Mobility, a strategic division that brings together breakthrough technologies, forward thinking, and transformative partnerships to shape the future of fleet and mobility management. The innovation lab is the first of several pillars within the Element Mobility division. TORONTO, July 29, 2025 (GLOBE NEWSWIRE) — Element Fleet Management Corp. (TSX:EFN) (“Element” or the “Company”), the largest publicly traded, pure-play automotive fleet manager in the world, today announced the launch of Element Mobility — a bold new division to advance next-generation fleet technologies, continuing Element’s leadership role in shaping the future of intelligent mobility. “Our industry is evolving at unprecedented speed, and Element Mobility...

Captivision, Inc. Announces Extension Granted by Nasdaq to Regain Compliance with Periodic Filing Requirement

Written by Customer Service on July 29, 2025. Posted in Public Companies.

MIAMI, July 29, 2025 (GLOBE NEWSWIRE) — Captivision Inc. (“Captivision” or the “Company”) (NASDAQ: CAPT), a pioneering manufacturer and global LED solution provider, announced that it has been informed that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request for continued listing on The Nasdaq Stock Market (“Nasdaq”), subject to certain conditions related to the Company’s ongoing efforts to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Rule”) The Company is working diligently with its independent auditor, KPMG Samjong Accounting Corp. (“KPMG”), to complete the restatement and re-audit of its financial statements. Captivision expects to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2024, on or before September 30, 2025. Pursuant to the Panel’s decision,...

UroGen Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 7th, 2025

Written by Customer Service on July 29, 2025. Posted in Public Companies.

Conference Call and Webcast Scheduled for Thursday, August 7th, 2025, at 10:00 AM ET PRINCETON, N.J., July 29, 2025 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report second quarter 2025 financial results on Thursday, August 7th, 2025, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time. A live public webcast of the earnings conference call can be accessed on UroGen’s Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days. About UroGen Pharma Ltd. UroGen is a biotech company dedicated to developing and commercializing...

SemiCab Wins Expanded Contract with Kellanova India for Transportation Services in India

Written by Customer Service on July 29, 2025. Posted in Public Companies.

New Expansion Makes SemiCab a Top Five Provider of Transportation Services to Kellanova India Fort Lauderdale, FL, July 29, 2025 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – an AI technology and consumer electronics holding company, today announced that its subsidiary, SMCB Solutions Private Limited (“SemiCab India”), has been awarded a large expansion to its Master Services Agreement with Kellanova India, one of the largest fast-moving consumer packaged goods producers in India. Under the terms of the services agreement, SemiCab India will provide managed transportation services to Kellanova India along the densely populated South-West-Central corridors in India. SemiCab’s managed services are powered by its AI-powered, cloud-based Collaborative Transportation Platform, which is designed to reduce...

Cerence AI Brings State-of-the-Art Voice Interaction to LG TVs with Human-Like Neural Text-to-Speech

Written by Customer Service on July 29, 2025. Posted in Public Companies.

Smart home leader LG leverages multi-lingual text-to-speech from Cerence AI to enable its TVs to deliver information via spoken voice BURLINGTON, Mass., July 29, 2025 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that LG Electronics Inc. is leveraging Cerence’s cloud neural text-to-speech (TTS) technology to power voice interaction across its global television lineup, bringing a natural and engaging experience to tens of millions of households. The announcement marks an important step in Cerence AI’s continued strategic expansion into new markets. LG TVs now feature Cerence’s AI-powered cloud neural TTS when the device is connected, as well as edge TTS, across 65 voices and languages, delivering high quality interaction and extensive...

Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th

Written by Customer Service on July 29, 2025. Posted in Earnings Releases And Operating Results.

Company to host public (L)earnings call on August 5th at 8:00 am ET / 6:00 am MT / 1:00 pm BST Salt Lake City, UT, July 29, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its second quarter 2025 financial results on Tuesday, August 5, 2025, before the open of the financial markets. Recursion will host a (L)earnings Call on August 5, 2025 at 8:00 am ET / 6:00 am MT / 1:00 pm BST. The company will broadcast the live stream from Recursion’s X (formerly Twitter), LinkedIn, and YouTube accounts. Investors, analysts, and the public will be able to ask questions of the company by submitting questions here: https://forms.gle/pEH9b7wv2RxbrFDR7. About RecursionRecursion (NASDAQ: RXRX) is a clinical...

Exagen Inc. Reports Strong Q2 2025 Results

Written by Customer Service on July 29, 2025. Posted in Earnings Releases And Operating Results.

CARLSBAD, Calif., July 29, 2025 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2025, and recent corporate updates. Three Months Ended June 30, Six Months Ended June 30, 2025 2024 2025 2024 (Unaudited, in thousands, exceptASP data) Revenue $ 17,202 $ 15,064 $ 32,700 $ 29,479 Gross margin 60.4 % 60.1 % 59.7 % 59.9 %Operating expenses $ 13,025 $ 11,643 $ 25,513 $ 23,244 Operating loss $ (2,630) $ (2,587) $ (5,995) $ (5,590) Net loss $ (4,439) $ (2,966) $ (8,191) $ (6,326) Adjusted EBITDA $ (1,721) $ (1,598) $ (4,229) $ (3,590) Cash and cash equivalents $ 30,033 $ 24,479 $ 30,033 $ 24,479 Trailing-twelve-month...

Sysco Reports Fourth Quarter and Full Year 2025 Results; Introduces FY26 Guidance

Written by Customer Service on July 29, 2025. Posted in Earnings Releases And Operating Results.

HOUSTON, July 29, 2025 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE: SYY) (“Sysco” or the “company”) today announced financial results for its 13-week fourth fiscal quarter and its fiscal year ended June 28, 2025. Key financial results for the fourth quarter of fiscal year 2025 include the following (comparisons are to the same period in fiscal year 2024):Sales increased 2.8%; U.S. Foodservice volume decreased 0.3%; Gross profit increased 3.9% to $4.0 billion; Operating income decreased 9.0% to $889 million, and adjusted operating income increased 1.1% to $1.1 billion1; Net earnings decreased 13.2% to $531 million, and adjusted net earnings increased 3.3% to $716 million1; EBITDA decreased 6.5% to $1.1 billion, and adjusted EBITDA increased 1.8% to $1.3 billion1,2; and EPS3 decreased 10.6% to $1.10, and adjusted EPS1 increased...

Month: July 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals